Swedbank AB Increases Holdings in Veeva Systems Inc. $VEEV

Swedbank AB increased its position in shares of Veeva Systems Inc. (NYSE:VEEVFree Report) by 5.2% in the third quarter, HoldingsChannel reports. The firm owned 1,092,175 shares of the technology company’s stock after acquiring an additional 53,558 shares during the quarter. Swedbank AB’s holdings in Veeva Systems were worth $325,370,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Sigma Planning Corp raised its position in Veeva Systems by 1.2% during the 2nd quarter. Sigma Planning Corp now owns 3,328 shares of the technology company’s stock worth $958,000 after buying an additional 39 shares during the last quarter. Keybank National Association OH raised its holdings in shares of Veeva Systems by 1.4% during the second quarter. Keybank National Association OH now owns 3,088 shares of the technology company’s stock worth $889,000 after purchasing an additional 42 shares during the last quarter. Facet Wealth Inc. lifted its position in Veeva Systems by 3.3% during the second quarter. Facet Wealth Inc. now owns 1,342 shares of the technology company’s stock valued at $381,000 after purchasing an additional 43 shares during the period. Triangle Securities Wealth Management lifted its position in Veeva Systems by 0.8% during the second quarter. Triangle Securities Wealth Management now owns 5,782 shares of the technology company’s stock valued at $1,665,000 after purchasing an additional 45 shares during the period. Finally, Emerald Advisers LLC boosted its holdings in Veeva Systems by 1.8% in the second quarter. Emerald Advisers LLC now owns 2,679 shares of the technology company’s stock valued at $771,000 after purchasing an additional 47 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on VEEV shares. Oppenheimer reiterated an “outperform” rating and set a $325.00 price objective on shares of Veeva Systems in a research note on Thursday, August 28th. Truist Financial raised their target price on Veeva Systems from $268.00 to $275.00 and gave the stock a “hold” rating in a report on Thursday, August 28th. Wall Street Zen downgraded Veeva Systems from a “buy” rating to a “hold” rating in a report on Saturday, December 6th. Canaccord Genuity Group reaffirmed a “buy” rating on shares of Veeva Systems in a research note on Tuesday, November 25th. Finally, Citigroup cut their target price on shares of Veeva Systems from $349.00 to $319.00 and set a “buy” rating for the company in a report on Monday, November 24th. Eighteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $307.42.

View Our Latest Stock Report on Veeva Systems

Insider Buying and Selling

In other news, insider Eleni Nitsa Zuppas sold 6,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the transaction, the insider owned 25,325 shares in the company, valued at $7,765,151.50. This trade represents a 19.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Jonathan Faddis sold 14,595 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.00, for a total value of $4,378,500.00. Following the completion of the transaction, the senior vice president directly owned 8,588 shares of the company’s stock, valued at approximately $2,576,400. This represents a 62.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 24,665 shares of company stock worth $7,438,000 in the last 90 days. Insiders own 10.30% of the company’s stock.

Veeva Systems Stock Performance

Veeva Systems stock opened at $224.32 on Wednesday. The stock has a market capitalization of $36.87 billion, a P/E ratio of 43.64, a P/E/G ratio of 1.65 and a beta of 1.05. The company’s fifty day moving average price is $262.93 and its 200 day moving average price is $275.91. Veeva Systems Inc. has a 1 year low of $201.54 and a 1 year high of $310.50.

Veeva Systems (NYSE:VEEVGet Free Report) last posted its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.09. Veeva Systems had a net margin of 27.93% and a return on equity of 13.68%. The company had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. During the same period in the prior year, the business posted $1.75 earnings per share. The firm’s revenue for the quarter was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. Sell-side analysts predict that Veeva Systems Inc. will post 4.35 EPS for the current year.

Veeva Systems Profile

(Free Report)

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

Featured Articles

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEVFree Report).

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.